Suchergebnisse - "Merola, Joseph F"

PubPharm (442)

1

Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis : a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials

enthalten in: The Journal of dermatological treatment | 2024

von Merola, J. | Armstrong, A. | Khattri, S. | +6

2

TYK2 : an emerging therapeutic target in rheumatic disease

enthalten in: Nature reviews. Rheumatology | 2024

von Morand, E. | Merola, J. | Tanaka, Y. | +2

3

Bimekizumab safety in moderate to severe plaque psoriasis : Rates of hepatic events and changes in liver parameters over 2 years in randomized phase 3/3b trials

enthalten in: Journal of the American Academy of Dermatology | 2024

von Lebwohl, M. | Merola, J. | Strober, B. | +9

4

Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases : A retrospective, observational, comparative cohort study using US claims data

enthalten in: Journal of the American Academy of Dermatology | 2024

von Merola, J. | Ertmer, B. | Liang, H. | +3

5

Expression of IL-4 in Tumors : A Safety Surrogate to Predict Cancer Survival Associated With Biologic Therapies

enthalten in: Journal of drugs in dermatology : JDD | 2024

von Klebanov, N. | Grant, C. | Smith, J. | +2

6

Generalized pustular psoriasis : A consensus statement from the National Psoriasis Foundation

enthalten in: Journal of the American Academy of Dermatology | 2024

von Armstrong, A. | Elston, C. | Elewski, B. | +32

7

Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab : Analysis of phase 2/3 randomized trials

enthalten in: Journal of the American Academy of Dermatology | 2024

von Blauvelt, A. | Armstrong, A. | Merola, J. | +6

8

Treatment of recalcitrant lupus erythematosus tumidus with deucravacitinib

enthalten in: JAAD case reports | 2024

von Zhang, A. | Gaffney, R. | Merola, J.

9

Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis : A subset analysis of two phase 3 randomized trials in plaque psoriasis

enthalten in: Journal of the American Academy of Dermatology | 2024

von Blauvelt, A. | Rich, P. | Sofen, H. | +11

10

Improvements in Patient-Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis : Real-World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

enthalten in: ACR open rheumatology | 2024

von Mease, P. | Ogdie, A. | Tesser, J. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[45]